Chlorine in PDB 3kka: Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2

All present enzymatic activity of Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2:
2.7.10.1;

The structure of Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2, PDB code: 3kka was solved by J.R.Walker, L.Yermekbayeva, C.Butler-Cole, J.Weigelt, C.Bountra, C.H.Arrowsmith, A.M.Edwards, A.Bochkarev, S.Dhe-Paganon, Structural Genomics Consortium (Sgc), with X-Ray Crystallography technique. A brief refinement statistics is given in the table below:

Resolution Low / High (Å)	30.44 / 2.40
Space group	P 21 21 21
Cell size a, b, c (Å), α, β, γ (°)	57.554, 56.071, 107.617, 90.00, 90.00, 90.00
R / Rfree (%)	20 / 23.5

The binding sites of Chlorine atom in the Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2 (pdb code 3kka). This binding sites where shown within 5.0 Angstroms radius around Chlorine atom.
In total only one binding site of Chlorine was determined in the Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2, PDB code: 3kka:

Chlorine binding site 1 out of 1 in the Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2


Mono view


Stereo pair view

A full contact list of Chlorine with other atoms in the Cl binding site number 1 of Co-Crystal Structure of the Sam Domains of EPHA1 and EPHA2 within 5.0Å range: probe atom residue distance (Å) B Occ B:Cl63 b:89.5 occ:1.00 O B:ARG926 3.2 41.3 1.0 N B:LYS928 3.2 38.0 1.0 C B:ARG926 3.4 39.6 1.0 N B:ARG929 3.5 40.2 1.0 NH1 B:ARG929 3.7 56.2 1.0 N B:MET927 3.8 37.4 1.0 CB B:LYS928 3.8 42.7 1.0 C B:MET927 3.8 35.9 1.0 CA B:LYS928 3.8 40.4 1.0 CA B:MET927 3.9 35.6 1.0 NE B:ARG929 4.0 51.8 1.0 CA B:ARG926 4.1 41.3 1.0 C B:LYS928 4.1 40.3 1.0 CZ B:ARG929 4.2 56.0 1.0 CB B:ARG929 4.4 41.2 1.0 CA B:ARG929 4.5 41.0 1.0 CB B:ARG926 4.7 44.1 1.0 O B:MET927 4.8 35.5 1.0

J.R.Walker, L.Yermekbayeva, C.Butler-Cole, J.Weigelt, C.Bountra, C.H.Arrowsmith, A.M.Edwards, A.Bochkarev, S.Dhe-Paganon. Co-Crystal Structure of the Sam Domains of Human Ephrin Type-A Receptor 1 and Human Ephrin Type-A Receptor 2 To Be Published.